ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,361Medicare Part D Prescriptions Filled, Including Refills

Rank: 128 out of 1383

$888K Total Retail Price of All Prescriptions

Rank: 81 out of 1383

324 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 324 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

24% of this provider’s 324 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 12,913 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
LEVOTHYROXINE SODIUM 625 545 1 4
FUROSEMIDE 457 414 2 7
POTASSIUM CHLORIDE 432 404 3 12
MIRTAZAPINE 419 361 4 51
HYDROCODONE-ACETAMINOPHEN 405 347 S3 5 1
SIMVASTATIN 368 255 6 2
NAMENDA 362 340 7 49
DONEPEZIL HCL 350 315 8 35
AMLODIPINE BESYLATE 336 280 9 6
WARFARIN SODIUM 286 224 10 13
METOPROLOL TARTRATE 265 229 11 9
RISPERIDONE 257 197 12 71
GABAPENTIN 236 179 13 11
CITALOPRAM HBR 222 189 14 15
DIVALPROEX SODIUM 206 176 15 78
QUETIAPINE FUMARATE 203 173 16 70
METFORMIN HCL 192 140 17 8
SERTRALINE HCL 175 149 18 21
CYMBALTA 168 116 19 53
ESCITALOPRAM OXALATE 165 149 20 99
ENALAPRIL MALEATE 163 129 21 75
DIVALPROEX SODIUM ER 151 90 22 200
ALBUTEROL SULFATE 146 126 23 124
LEVOFLOXACIN 144 133 24 88
CLOPIDOGREL 140 123 25 28
LANTUS 133 94 26 50
OMEPRAZOLE 132 125 27 5
RANITIDINE HCL 122 116 28 19
HYDRALAZINE HCL 122 98 28 86
TAMSULOSIN HCL 121 100 30 30
CLONIDINE HCL 116 90 31 44
TRAZODONE HCL 114 99 32 36
BUMETANIDE 113 110 33 122
OLANZAPINE 109 87 34 164
EXELON 109 84 34 117
NOVOLOG 107 86 36 139
PLAVIX 104 94 37 43
PRIMIDONE 104 74 37 207
ISOSORBIDE MONONITRATE ER 104 86 37 66
ATENOLOL 101 75 40 16
LACTULOSE 101 98 40 128
HYDROCHLOROTHIAZIDE 101 92 40 10
LISINOPRIL 100 68 43 3
NITROGLYCERIN PATCH 100 89 43 177
AZITHROMYCIN 97 67 45 41
DIGOXIN 95 86 46 59
FLUTICASONE PROPIONATE 93 67 47 39
SULFAMETHOXAZOLE-TRIMETHOPRIM 90 81 48 89
NYSTATIN 87 71 49 132
BENAZEPRIL HCL 86 69 50 38
BENZTROPINE MESYLATE 85 66 R 51 197
PAROXETINE HCL 85 71 51 55
PANTOPRAZOLE SODIUM 83 81 53 32
PROMETHAZINE HCL 83 65 R 53 56
IPRATROPIUM BROMIDE 81 63 55 174
SPIRIVA 81 59 55 45
ADVAIR DISKUS 80 62 57 63
CARVEDILOL 79 70 58 24
LEVETIRACETAM 78 27 59 134
NEXIUM 72 50 60 26
LATANOPROST 72 72 60 239
CEFTRIAXONE 71 63 62 175
ATORVASTATIN CALCIUM 70 70 63 18
METOPROLOL SUCCINATE 68 61 64 29
DILTIAZEM 24HR CD 63 63 65 95
LYRICA 62 47 66 72
DILTIAZEM HCL 61 56 67 203
SEROQUEL 61 55 67 130
VENLAFAXINE HCL ER 60 44 69 102
GLYBURIDE 60 60 R 69 46
CYCLOBENZAPRINE HCL 59 32 R 71 69
BACLOFEN 59 39 71 118
HUMALOG 57 56 73 176
RESTASIS 56 56 74 361
PREDNISONE 53 38 75 40
IPRATROPIUM-ALBUTEROL 53 48 75 138
CARBIDOPA-LEVODOPA 53 53 75 108
ZOLPIDEM TARTRATE 53 32 75 17
CARBAMAZEPINE 52 41 79 224
SOTALOL 52 45 79 278
SPIRONOLACTONE 52 40 79 67
OXYBUTYNIN CHLORIDE ER 51 51 82 173
POLYETHYLENE GLYCOL 3350 50 50 83 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 9, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.